AGF Investments LLC’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-101
Closed -$4K 520
2020
Q3
$4K Sell
101
-1,886
-95% -$72.7K ﹤0.01% 480
2020
Q2
$70K Buy
1,987
+1,863
+1,502% +$67.1K 0.01% 384
2020
Q1
$4K Sell
124
-4,782
-97% -$187K ﹤0.01% 521
2019
Q4
$222K Sell
4,906
-1,742
-26% -$72.9K 0.04% 388
2019
Q3
$271K Buy
6,648
+182
+3% +$7.71K 0.06% 329
2019
Q2
$278K Buy
6,466
+6,388
+8,190% +$246K 0.06% 341
2019
Q1
$3K Buy
+78
New +$2.98K ﹤0.01% 597
2018
Q1
Sell
-1,512
Closed -$38K 684
2017
Q4
$38K Buy
+1,512
New +$41.7K 0.01% 273
2017
Q2
Sell
-1,828
Closed -$46K 747
2017
Q1
$46K Sell
1,828
-684
-27% -$16.6K 0.01% 189
2016
Q4
$55K Buy
+2,512
New +$54.8K 0.01% 220

Other funds holding BSX

AGF Investments LLC's BSX Position: Q4 2020 in Review

AGF Investments LLC sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 101 shares — an estimated $4K sold.

AGF Investments LLC first reported a position in BSX in Q4 2016 and held it in 10 quarters. The position peaked at $278K in Q2 2019. 864 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

  • AGF Investments LLC reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
  • AGF Investments LLC sold 101 Boston Scientific shares in Q4 2020, an estimated $4K.
  • AGF Investments LLC first reported a position in Boston Scientific in Q4 2016 and held it in 10 quarters.
  • AGF Investments LLC's Boston Scientific position peaked at $278K in Q2 2019.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on AGF Investments LLC's 13F filing for Q4 2020, filed 8 Feb 2021.